XML 35 R17.htm IDEA: XBRL DOCUMENT v2.4.1.9
Organization, Use of Estimates and Basis of Presentation (Tables)
9 Months Ended
Jan. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
 
 
Three Months Ended
 
 
Nine Months Ended
 
 
 
January 31,
 
 
January 31,
 
 
 
2015
 
 
2014
 
 
2015
 
 
2014
 
Basic loss per share computation
 
 
 
 
 
 
 
 
 
 
 
 
Net loss attributable to common stockholders
 
$
(2,816,465
)
 
$
(574,207
)
 
$
(9,462,281
)
 
$
(5,133,684
)
Weighted Average common shares - basic
 
 
66,893,364
 
 
 
66,867,114
 
 
 
66,890,929
 
 
 
66,860,792
 
Basic net loss per share
 
$
(0.04
)
 
$
(0.01
)
 
$
(0.14
)
 
$
(0.08
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diluted loss per share computation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss attributable to common stockholders
 
$
(2,816,465
)
 
$
(574,207
)
 
$
(9,462,281
)
 
$
(5,133,684
)
Less: Gain on derivative warrant liability
 
 
620,687
 
 
 
845,774
 
 
 
1,401,314
 
 
 
-
 
Loss available to common stockholders
 
$
(3,437,152
)
 
$
(1,419,981
)
 
$
(10,863,595
)
 
$
(5,133,684
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted Average common shares
 
 
66,893,364
 
 
 
66,867,114
 
 
 
66,890,929
 
 
 
66,860,792
 
Incremental shares from assumed exercise of warrants and stock options
 
 
352,213
 
 
 
-
 
 
 
352,213
 
 
 
-
 
Adjusted weighted average share - diluted
 
 
67,245,577
 
 
 
66,867,114
 
 
 
67,243,142
 
 
 
66,860,792
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diluted net loss per share
 
$
(0.05
)
 
$
(0.02
)
 
$
(0.16
)
 
$
(0.08
)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
The following table reflects the total potential share-based instruments outstanding at January 31, 2015 and 2014 that could have an effect on the future computation of dilution per common share:
 
 
 
January 31,
 
 
 
2015
 
 
2014
 
 
 
 
 
 
 
 
Stock options
 
 
23,990,008
 
 
 
22,633,955
 
Warrants
 
 
3,126,667
 
 
 
3,276,667
 
 
 
 
 
 
 
 
 
 
Total common stock equivalents
 
 
27,116,675
 
 
 
25,910,622